Assistant Professorjay.firstname.lastname@example.org (216) 844-7118 (o)
Dr. Jay Wasman received a B.A. with Honors in Biology from the University of Pennsylvania in 1985. His M.D. was completed at Case in 1989. He continued on as a Resident in Anatomic and Clinical Pathology at University Hospitals of Cleveland, later becoming Chief Resident. Dr. Wasman completed a fellowship in Surgical Pathology and Cytology in 1993 at University Hospitals. The next two years were spent as Staff Pathologist at Montgomery Hospital of Pennsylvania. There he soon became Associate Chairman of Pathology until 2001 when he came back to Case as an Instructor. Since 2004, Dr. Wasman has been an Assistant Professor of Pathology at Case's School of Medicine.
1985, University of Pennsylvania
Medical / Professional School(s)
1989, Case Western Reserve University School of Medicine
1993, Anatomic and Clinical Pathology - University Hospitals of Cleveland
1994, Cytopathology - University Hospitals of Cleveland
Breast Cancer, Cytopathology, Head and Neck Oncology, Head and Neck Pathology, Surgical Pathology
Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid.
Savvides P, Nagaiah G, Lavertu P, Fu P, Wright JJ, Chapman R, Wasman J, Dowlati A, Remick SC.
Thyroid. 2013 May;23(5):600-4.
Metastatic Crohn disease: a rare cutaneous entity.
Siroy A, Wasman J.
Arch Pathol Lab Med. 2012 Mar;136(3):329-32.
Transmastoid extradural-intracranial approach for repair of transtemporal meningoencephalocele: a review of 31 consecutive cases.
Semaan MT, Gilpin DA, Hsu DP, Wasman JK, Megerian CA.
Laryngoscope. 2011 Aug;121(8):1765-72.
Parathyroid hormone-related protein: an unusual mechanism for hypercalcemia in sarcoidosis.
Krikorian A, Shah S, Wasman J.
Endocr Pract. 2011 Jul-Aug;17(4):e84-6.
Glandular cells in vaginal cytology Papanicolaou tests in patients with hysterectomy for endometrial adenocarcinoma.
Steele E, Umar SA, Bomeisl P, Miedler J, Zanotti KM, Wasman JK, Hunt DC, Abdul-Karim FW.
Diagn Cytopathol. 2012 Feb;40(2):138-40.